PharmaShots | Incisive News in 3 Shots

Subscribe Now

Proliferative Vitreoretinopathy

Aldeyra's ADX-2191 Receives FDA's Fast Track Designation to Prevent Proliferative Vitreoretinopathy

Aldeyra's ADX-2191 Receives FDA's Fast Track Designation to Prevent Proliferative Vitreoretinopathy

September 24, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us